ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,225.99
0.06%
Dow Jones
39,570.23
0.15%
US Dollar vs MXN
16.7886
0.04%
Brent Oil
83.555
1.42%
Bitcoin
62,879.05
2.33%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE
  6. Shield Therapeutics Plc (STX)

  7. Shield Therapeutics Plc (STX) Noticias

STX

Shield Therapeutics (STX)

Shield Therapeutics Plc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:LSE:STX
FechaHoraFuenteTítuloSímboloCompañía
10/05/202409:30RNS Regulatory NewsShield Therapeutics PLC Audited results for the year ended 31 Dec 2023LSE:STXShield Therapeutics Plc
30/04/202413:54Alliance NewsAlliance NewsEARNINGS AND TRADING: Software Circle & Beximco report higher revenueLSE:STXShield Therapeutics Plc
30/04/202401:00RNS Regulatory NewsShield Therapeutics PLC Business Update for Q1 2024LSE:STXShield Therapeutics Plc
16/04/202401:00RNS Regulatory NewsShield Therapeutics PLC Notice of ResultsLSE:STXShield Therapeutics Plc
21/02/202406:36Alliance NewsAlliance NewsShield Therapeutics sinks as strong performance marred by data issuesLSE:STXShield Therapeutics Plc
21/02/202401:00RNS Regulatory NewsShield Therapeutics PLC Unaudited Full Year Trading UpdateLSE:STXShield Therapeutics Plc
09/01/202405:33Alliance NewsAlliance NewsIN BRIEF: Shield Therapeutics hires former Akili leader as new CFOLSE:STXShield Therapeutics Plc
09/01/202401:00UK RegulatoryShield Therapeutics PLC Appointment of new Chief Financial OfficerLSE:STXShield Therapeutics Plc
07/12/202309:31Alliance NewsAlliance NewsTRADING UPDATES: Comptoir opens restaurant; Intercede wins contractLSE:STXShield Therapeutics Plc
07/12/202301:00UK RegulatoryShield Therapeutics PLC Q3 2023 U.S. Commercial HighlightsLSE:STXShield Therapeutics Plc
27/11/202311:24UK RegulatoryShield Therapeutics PLC PDMR Transaction NotificationLSE:STXShield Therapeutics Plc
20/10/202305:45RNS Non-RegulatoryShield Therapeutics PLC Abstract to be presented at Healthcare ConferenceLSE:STXShield Therapeutics Plc
12/10/202305:14Alliance NewsAlliance NewsIN BRIEF: Shield Therapeutics Chief Financial Officer Rudolf to leaveLSE:STXShield Therapeutics Plc
12/10/202301:00UK RegulatoryShield Therapeutics PLC Chief Financial Officer TransitionLSE:STXShield Therapeutics Plc
03/10/202311:14Alliance NewsAlliance NewsTRADING UPDATES: Aston Martin CEO ups stake; Alkemy's lithium dealLSE:STXShield Therapeutics Plc
03/10/202309:00UK RegulatoryShield Therapeutics PLC Result of REX Retail OfferLSE:STXShield Therapeutics Plc
03/10/202308:29Alliance NewsAlliance NewsShield Therapeutics completes USD20 million SWK financingLSE:STXShield Therapeutics Plc
03/10/202301:00UK RegulatoryShield Therapeutics PLC Block listing Interim ReturnLSE:STXShield Therapeutics Plc
03/10/202301:00UK RegulatoryShield Therapeutics PLC Completion of SWK FinancingLSE:STXShield Therapeutics Plc
28/09/202308:54Alliance NewsAlliance NewsUPDATE: Shield Therapeutics completes GBP5 million share placingLSE:STXShield Therapeutics Plc
28/09/202306:50UK RegulatoryShield Therapeutics PLC Successful completion of US$6.1m Equity FundraiseLSE:STXShield Therapeutics Plc
28/09/202305:30Alliance NewsAlliance NewsShield Therapeutics raises funds for US sales push as loss narrowsLSE:STXShield Therapeutics Plc
28/09/202301:02UK RegulatoryShield Therapeutics PLC REX Retail OfferLSE:STXShield Therapeutics Plc
28/09/202301:01UK RegulatoryShield Therapeutics PLC $20m secured debt facility &proposed equity raiseLSE:STXShield Therapeutics Plc
28/09/202301:00UK RegulatoryShield Therapeutics PLC Interim results update and business updateLSE:STXShield Therapeutics Plc
06/09/202314:33Alliance NewsAlliance NewsIN BRIEF: Shield Therapeutics changes reporting currency to US dollarsLSE:STXShield Therapeutics Plc
06/09/202301:00UK RegulatoryShield Therapeutics PLC Notice of Results and Change in reporting currencyLSE:STXShield Therapeutics Plc
06/08/202311:07Alliance NewsAlliance NewsCORRECT: Biogens, Sage Therapeutics postpartum depression drug okayedLSE:STXShield Therapeutics Plc
06/08/202308:17Alliance NewsAlliance NewsBiogens, Sage Therapeutics postpartum depression treatment approvedLSE:STXShield Therapeutics Plc
24/07/202308:27UK RegulatoryShield Therapeutics PLC Holding(s) in CompanyLSE:STXShield Therapeutics Plc
 Showing the most relevant articles for your search:LSE:STX

Su Consulta Reciente

NASDAQ
NVDA
NVIDIA
USOTC
ADDYY
Adidas (QX)
FX
USDMXN
US Dollar vs MXN
NASDAQ
AMZN
Amazon.com
AMEX
SPY
SPDR S&P 500
CCOM
US30
US 30
USOTC
BNPQY
BNP Paribas (QX)
CCOM
OILBRENT
Brent Oil
COIN
SOLUSD
Solana
NASDAQ
TSLA
Tesla
CCOM
SILVER
SILVER
FX
EURMXN
Euro vs MXN
FX
EURUSD
Euro vs US Dollar
COIN
ETHUSD
Ethereum
NYSE
MRK
Merck
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados